Clinical Trial Update: The Impact of Vericiguat on Microvascular Function in Patients with Documented Vasospastic Angina Pectoris [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the effect of vericiguat on microvascular function in patients with vasospastic angina is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vasospastic Angina

Drugs mentioned

• Verquvo (vericiguat)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Vasospastic Angina | Phase 2 | Status: NOT_YET_RECRUITING